These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38742824)
1. Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Dousa KM; Shin E; Kurz SG; Plummer M; Nantongo M; Bethel CR; Taracila MA; Nguyen DC; Kreiswith BN; Daley CL; Remy KE; Holland SM; Bonomo RA mBio; 2024 Jun; 15(6):e0060924. PubMed ID: 38742824 [TBL] [Abstract][Full Text] [Related]
2. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action. Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757 [TBL] [Abstract][Full Text] [Related]
3. Insights into the l,d-Transpeptidases and d,d-Carboxypeptidase of Mycobacterium abscessus: Ceftaroline, Imipenem, and Novel Diazabicyclooctane Inhibitors. Dousa KM; Kurz SG; Taracila MA; Bonfield T; Bethel CR; Barnes MD; Selvaraju S; Abdelhamed AM; Kreiswirth BN; Boom WH; Kasperbauer SH; Daley CL; Bonomo RA Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32393499 [No Abstract] [Full Text] [Related]
4. Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins. Kumar P; Chauhan V; Silva JRA; Lameira J; d'Andrea FB; Li SG; Ginell SL; Freundlich JS; Alves CN; Bailey S; Cohen KA; Lamichhane G Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760902 [TBL] [Abstract][Full Text] [Related]
10. Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease. Pozuelo Torres M; van Ingen J Clin Microbiol Infect; 2024 Jun; 30(6):738-742. PubMed ID: 38527611 [TBL] [Abstract][Full Text] [Related]
11. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria. Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769 [TBL] [Abstract][Full Text] [Related]
12. Synergistic Efficacy of β-Lactam Combinations against Story-Roller E; Maggioncalda EC; Lamichhane G Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109979 [No Abstract] [Full Text] [Related]